HARRISVACCINES, INC.

AMES, IA · Founded 2008 · Agritech · Private

Replicon particle vaccine for white spot syndrome virus in shrimp

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Agritech
Headquarters
AMES, IA
Founded
2008
Latest Form D
$4.2M, Sep 2011
Total capital
$5.7M
Federal grants
$639K
3 awards · 2010–2014
Rank in peer group#17 of 35
Private capital raised
$4.2M
1 Form D · last Sep 2011
181 months since last filing
Federal contracts
$877K
1 award · Homeland Security
Rank in Agritech#36 of 882
Granted patents
3
6 pending · first 2014
Rank in peer group#4 of 35

Capital timeline

20102011201220132014FEDERAL ↑EQUITY ↓Cumulative $5.7M$80K$460K$877K$99K1st Form D$4.2M
20102011201220132014FEDERAL ↑EQUITY ↓Cumulative $5.7M$80K$460K$877K$99K1st Form D$4.2M

Latest events

  • Federal grantAgriculture · Next Generation Vaccine For Infectious Bovine Keratoconjuctivitis$99K
  • Federal contractHomeland Security · Igf::ot::igf Division: Chemical&biological Ppa: Rd&i Program: Bioagent Attack Resiliency Project: Fad Vaccines&diagnostics Performer: Harrisvaccines, Inc. Appropriation Year: FY12 (24 Funds) Budget Authority: Three-year R&d Funds Project Manager: Dr. Bruce Harper Lead Support Staff: Robert Orr, 202-254-6606 Alc: 70-08-1513 Tas: 70240800 Description: The Purpose Of This Requisition Is To Provide Funding To Harrisvaccines, Inc. For Replicon-based Rapid Response Vaccines For Foot-an$877K
  • Private capital raisedForm D · SEC · 1st filing$4.2M
  • Federal grantAgriculture · Replicon Particle Vaccine For White Spot Syndrome Virus In Marine Shrimp Phase II$460K
  • Federal grantAgriculture · Replicon Particle Vaccine For White Spot Syndrome Virus In Marine Shrimp$80K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

15months

from HARRISVACCINES, INC.’s first federal award to its first private round.

First federal award · Jun 2010
Agriculture · $80K
First Form D · Sep 2011
$4.2M · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 35 peers

Line = median

Agritech · Molecule

  • Federal grants#17 · top 49%
  • Granted patents#4 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • D. L. HarrisExecutive Officer, DirectorNamed in SEC Form D filings
  • Michael L. UpahExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 9
Show all 9 patent records

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .